Genentech
SUSVIMO
Manufacturer:
Genentech
Name:
SUSVIMO
HCPCS Code Descriptor:
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
Category:
J Code
HCPCS:
J2779
NDC(s):
50242-0078-55, 50242-0078-12
Primary Type:
Opthalmic
Generic Status:
Single-Source
Route of Administration:
Intraocular
About:
SUSVIMO is an Opthalmic drug manufactured by Genentech and administered via the Intraocular route of administration. The J Code: J2779 is aligned to the drug SUSVIMO.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/22
HCPCS Effective Date:
7/1/22
HCPCS Short Description:
Inj, susvimo 0.1 mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/SUSVIMO-Billing-Coding-for-wet-AMD.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation